Salisa Hauptmann

Salisa Hauptmann is a seasoned regulatory affairs executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Chief Regulatory Officer and Sr. Vice President of Regulatory Affairs at BioCryst Pharmaceuticals, Inc. since January 2021, Salisa has held significant leadership positions at Merz Aesthetics, Merz Pharma, Merz North America, GlaxoSmithKline, Stiefel (a GSK company), Chiron/Novartis, Berlex Laboratories, and Dey Labs. Salisa's educational background includes a Master of Public Health from Webster University and a Bachelor of Arts from the University of California, Davis.